While MLD is a monogenic disease, whose severity can be largely explained by the residual activity of two enzymes, ARSA and PSAP, many human diseases are polygenic, or have strong polygenic backgrounds that can influence the penetrance of mutations in genes associated with monogenic disease (Khan et al, 2023). This evidence concerns the gene PSAP and metachromatic leukodystrophy.